Clinical trials are research studies that discover whether a medical treatment, strategy, or device is effective and safe for humans. There are four stages of clinical trials: phase Ι, phase ΙΙ, phase ΙΙΙ, and phase ΙV. Identification of pharmacological actions and tolerability is done in phase I. Phase ΙΙ evaluates drug safety and efficacy. Phase III involves the evaluation of risk benefit ratio and determination of dosage interval. Epidemiological data, efficacy, and safety within large diverse populations and pharmacoeconomics are identified in phase IV.
Clinical trials are complex activities that require synchronization of several different functions and processes. A pharmaceutical manufacturer’s primary goal in any clinical study is to optimize clinical trial supplies so that packaged investigational materials are distributed to patients enrolled in a clinical trial on time. These activities include, but are not limited to, project management, clinical packaging, randomization generation, labeling, supply chain logistics, blinding, distribution, return drug accountability, and destruction.
Obtain Report Details @
The clinical trial supplies market can be segmented based on products and services, therapeutic area, and region. In terms of products and services, the market can be categorized into manufacturing, packaging, logistics, and distribution. Based on therapeutic area, the clinical trial supply market can be segmented into oncology, cardiovascular diseases, neurological diseases, respiratory diseases, orthopedics, and others. In terms of end-user, the market can be segregated into contract research organizations, pharmaceutical & biotechnology companies, academic & research institutes, and others. In terms of region, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The global clinical trials supplies market is witnessing strong growth due to the increasing prevalence of chronic diseases such as cancer, epilepsy, and HIV; rising demand for outsourcing of drug discovery services, and increased emphasis on determining toxicity level in early stages of drug discovery. Additionally, increasing number of life sciences research in various countries and rising government funding for the development of new drugs are likely to propel the clinical trial supplies market. New entrants are focusing on new technologies and launch of new products in the market. However, shortage of trained professionals and lack of infrastructure are expected to hamper the growth of the market.
North America accounted for the largest share of the clinical trial supplies market due to high number of research and development activities in the area of drug discovery, advanced health care infrastructure, and presence of multinational pharmaceutical and biotechnology companies that carry out clinical trials. Europe accounted for the second largest share in terms of revenue owing to high health care investment and rising government funding. Asia Pacific is also witnessing significant growth due to rising unmet health care needs and increased government funding to research activities. Moreover, major pharmaceutical companies are outsourcing their drug development services to various countries such as China, Singapore, Malaysia, and India, which is propelling the growth of the clinical trial supplies market in the region. Middle East and Latin America are expected to be the prospective markets due growing access to information, high cancer burden, improving patient education, and access to new drugs for research centers. However, long timeline for regulatory approval, lack of training, lack of economic investment, and lack of personnel participating in clinical research in Latin America and Middle East are expected to restrain the clinical trial supplies market.
Key players operating in the clinical trial supplies market are Alamc Group Ltd., Amatsigroup, ADAllen Pharma, Durbin plc, Biocair, Catalent Pharma Solutions, Inc., KLIFO A/S, Movianto, Rubicon Research Pvt. Ltd., PCI Services, Patheon, Inc., PAREXEL International Corporation, and Sharp Packaging Services.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Fill the form for an exclusive sample of this report @
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Browse market research blog: